Showing results (501-510 of 868) with videos related to

Sort By:
Pageof 87
The New England Journal of Medicine|December 11, 2012
Apixaban for extended treatment of venous thromboembolismGiancarlo Agnelli, Harry R Buller, Alexander Cohen, et al.
Thrombosis and Haemostasis|March 20, 2015
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradationSara J Henderson, Alan R Stafford, Beverly A Leslie, et al.
JAMA|January 15, 2020
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 12, 2014
Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanismsTravis J Gould, Trang T Vu, Laura L Swystun, et al.
Thrombosis and Haemostasis|October 23, 2015
Zinc promotes clot stability by accelerating clot formation and modifying fibrin structureSara J Henderson, Jing Xia, Huayin Wu, et al.
European Journal of Haematology|October 22, 2024
Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE StudyJohannes Oldenburg, Charles Hay, Flora Peyvandi, et al.
Haematologica|August 30, 2008
Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing patternClaudia Dall'Osso, Ilaria Guella, Stefano Duga, et al.
Blood Advances|February 5, 2024
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2AOmid Seidizadeh, Luca Mollica, Serena Zambarbieri, et al.
The Journal of Biological Chemistry|December 18, 2001
Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogenThomas J Podor, Stephanie Campbell, Paul Chindemi, et al.
RMD Open|November 2, 2022
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitorsJeffrey I Weitz, Zoltán Szekanecz, Christina Charles-Schoeman, et al.
Pageof 87